Capital Commitment in Indian Pharma

Private Resolve, Public Support — and Who Is Ready for the Innovation Pivot

Earlier this week, I had a very interesting conversation with an acquaintance in Indian pharma. “Does our industry survive on government sops, or is PLI propping it up?” he wondered. “Without incentives from the government would our growth collapse?” I prodded further. We were not discussing if pharma would go belly up. We were talking about the proceed…